Georgia PANS PANDAS Updates
Call to Action: Call and email the Georgia Senate Health and Human Services Committee to vote yes for HB1484 now through the weekend. The meeting and vote are Monday at 7:00 a.m. CTA...
Call to Action: Call and email the Georgia Senate Health and Human Services Committee to vote yes for HB1484 now through the weekend. The meeting and vote are Monday at 7:00 a.m. CTA...
Thank you for having ASPIRE come talk to your school about PANS PANDAS. Please take a minute to fill out the survey below. School Resources for PANS PANDAS PANS @School Main Website Section Toolkits...
Bonnie Kaplan at the University of Calgary in the Behavioural Research Unit / Dept of Paediatrics has worked with hundreds of children and adults to develop a way to learn how to swallow pills. This...
Pedijatrijsko autoimuno neuropsihijatrijsko oboljenje udruženo sa streptokokom
Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection
Jasmina Škorić1, Bojan Pavković1. 1 Dom zdravlja Dr Simo Milošević’, Beograd, Srbija
http://prevped.preventivnapedijatrija.rs/index.php/casopis/article/download/41/24
Conclusion: The patient showed signs of improvement after the intravenous administration of immunoglobulin which confirmed the underlying immunological aspect of the disease. Additionally, serologic test results that showed elevated antistreptolysin O titer and antideoxyribonuclease–B titer indicated streptococcal etiology. Precisely, these misdirected antibodies set off an inflammatory response that led to the basal ganglia damage resulting in behavioral changes, motor, cognitive and emotional disorders.
PANDAS in an Adult?: A Case Report. Deshmukh RP, Mane AB, Singh S.Ind J Priv Psychiatry 2022; 16 (1):44-45. DOI: 10.5005/jp-journals-10067-0104
“We report a case in order to suggest that we should be alert while assessing OCD in young patients, as it might be secondary to streptococcal infection. This has therapeutic implications. Trials of immunomodulator therapy can be given as suggested in a few kinds of literature. Although still experimental, it may have potential for the future, especially in those not responding to conventional treatment… This report might suggest that PANDAS-like syndrome may occur in adults also. We should be cautious of this syndrome during treatment.”
Idaho’s HCR 30 for a PANDAS/PANS Awareness Day Passed Unanimously Bill Information: ID HCR030 States findings of the Legislature and recognizes October 9, 2022, as PANDAS/PANS Awareness Day. ...
Rhode Island Update & New Call To Action Senate Bill No. 2203 Bill Update: 03/03/2022 Committee recommended measure be held for further study Bill Information: Senate Bill No. 2203 – AN ACT...
Octapharma/PACE Foundation IVIG Trial In cooperation with Octapharma, the PACE Foundation is pleased to announce that they are now actively recruiting candidates for the National PANS IVIG Trial....
Neuroinflammation in a Rat Model of Tourette Syndrome, Zhongling Ke, Yanhui Chen, Guofeng Chen, Yanyan Liu, Neuroinflammation in a Rat Model of Tourette Syndrome, Frontiers in Behavioral Neuroscience, Vol 16, Front. Behav. Neurosci., 10 March 2022, DOI: 10.3389/fnbeh.2022.710116
Conclusion: The IDPN-induced TS rats had significant neuroinflammation in the brain, and the interaction between dopamine (DA) dysregulation and immune dysfunction may play a vital role in the pathogenic mechanisms of TS.
Are you in New York State? Help secure legislation mandating insurance coverage for PANS PANDAS in New York. No experience...
Washington House Resolution 4653 Passed Bill Information: HR 4653 – 2021-22- Honoring patients and families affected by PANDAS/PANS. Bill Status Link: Washington.Gov Link Bill Language:...
Bambauer R, Schiel R. Therapeutic Apheresis and Immunosuppression in Immunologic Diseases: A Review and OwnObservations. Clin Immunol Res. 2021; 5(2): 1-36. ISSN 2639-8486
“TA should be reserved for treatment of children and adolescents
who are severely affected by PANDAS. In such patients, it
appears to be safe, well-tolerated, and beneficial treatment
option [130]. Bien et al reported in 2020, besides the first-line
interventions of steroids, IVIG, and TA as second-line treatments
cyclophosphamide or rituximab [131].”